Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Confidentiality arrangement between EU and Brazilian regulatory authorities 6 Maggio 2021 News Human Medicines Becoming a member of one of EMA’s scientific advisory groups 5 Maggio 2021 News Human Corporate EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated 4 Maggio 2021 News Human COVID-19 Vaccines EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15 3 Maggio 2021 News Human COVID-19 Vaccines EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen 29 Aprile 2021 News Human COVID-19 Medicines EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe 26 Aprile 2021 News Human AstraZeneca’s COVID-19 vaccine: benefits and risks in context 23 Aprile 2021 News Human COVID-19 Vaccines Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from BioNTech/Pfizer and Moderna 23 Aprile 2021 News Human COVID-19 Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2021 23 Aprile 2021 News Human Generic and hybrid medicines Medicines Referrals New treatment for rare autoimmune disease of nerve cells 23 Aprile 2021 News Human Medicines 1 … 61 62 63 64 65 Page 65 of 379 66 67 68 69 … 379
Confidentiality arrangement between EU and Brazilian regulatory authorities 6 Maggio 2021 News Human Medicines
EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated 4 Maggio 2021 News Human COVID-19 Vaccines
EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15 3 Maggio 2021 News Human COVID-19 Vaccines
EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen 29 Aprile 2021 News Human COVID-19 Medicines
EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe 26 Aprile 2021 News Human
AstraZeneca’s COVID-19 vaccine: benefits and risks in context 23 Aprile 2021 News Human COVID-19 Vaccines
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from BioNTech/Pfizer and Moderna 23 Aprile 2021 News Human COVID-19 Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2021 23 Aprile 2021 News Human Generic and hybrid medicines Medicines Referrals